France-based Adcytherix has completed a Series A funding round, raising €105m ($122m) earmarked for expediting the ADC ...

The AAM’s Giuseppe Randazzo warns that the generics business could become unsustainable in the future if the market dynamics ...

EMD Serono agreed to provide direct-to-consumer (DTC) sales of its entire range of IVF therapies, including Ovidrel ...

Tubulis has completed a Series C, securing €308m ($361m) to be directed towards advancing clinical development of its ADC ...

Novo Nordisk will now run a Phase III trial for Omeros' former lead asset, zaltenibart in rare blood disorder, PNH.

With a legacy rooted in global scientific excellence, Sweden is quietly building one of Europe’s most dynamic biotech ...

AstraZeneca has unveiled a newly expanded manufacturing facility in Texas to the tune of $445m, as the drugmaker aims to meet ...

Just a year after emerging from stealth with a nearly half a billion dollars, Kailera Therapeutics has reached another ...

A consortium led by Nordic Capital and Permira has raised its bid, though certain shareholder stances remain firm.

While established US biotech hubs may still rule the roost, emerging competitors are looking to grab a larger slice of the ...

Oceanpine Capital is to acquire an 80% equity stake in Beijing Jacoray Pharmaceutical Technology for 200m yuan ($28m).

The WHO calls for increased policy focus on neurological disorders like Alzheimer’s disease, an indication that has seen ...